Compass Pathways Reports Q1 Financial Results, With Increased R&D Expenses Compared To 2021
New Study To Evaluate Magic Mushroom's Therapeutic Potential On Autistic Adults
UK: COMPASS Pathways Forms Partnership To Launch Centre For Mental Health Research And Innovation
Worthy Or Superfluous? Psychedelics Experts Discuss The Sector's Ongoing Patent Debate